Michigan lets owners claim lost or abandoned property online. Unlike other states, Michigan doesn’t list small amounts, which allowed it to keep nearly $190 million.

Michigan holds — and has already spent most of — more than $2 billion that it does not technically own. It’s your money. And critics say the state should do more to give it back.

Jeanice Kerr Swift reached a deal with the board to leave Oct. 31 after a decade leading the district. The agreement followed months of tension with some board members and parents, including over special education

Negotiations between the United Auto Workers and the Big Three automakers show some progress, but the union is planning a staggered walkout that will target Ford, GM and Stellantis at the same time.

Along with eliminating a 24-hour waiting period, legislators want Michigan to wipe away decades-old laws banning the use of Medicaid to fund abortions for low-income residents. Protests are planned.

Democrats and Republicans largely agree: there’s a teacher shortage. A bipartisan bill is aimed to help address the problem in the short term.

The new shots are one part of a new triple-vaccine protection against three respiratory threats: COVID, flu and RSV. Here’s what the experts say about which groups should get what.

MSU has yet to offer detailed answers on what officials knew, and who made key decisions on how to handle a sexual harassment complaint against its head football coach. MSU said it will say no more for now.

For $100, Michigan drivers could adorn their cars with blue ‘Great Lakes’ or black ‘Great Lake State’ plates under new Senate legislation. Money earned would go to fixing Michigan roads.

The Nishimura comet was the most visible Tuesday, but sky watchers will be able to see it all week long as it approaches the sun this weekend.

The Citizens Research Council of Michigan suggests the state should invest heavily in roads and power lines if it wants to jump-start stagnant population.

Democrats want a nonpartisan board to set maximum prices for some drugs. Foes worry the move could hamper research and do little to lower costs.